Latest Breaking News On - Edward feener - Page 1 : comparemela.com

Insider Sell: Chief Scientific Officer Edward Feener Sells 17,321 Shares of KalVista

Edward Feener, Chief Scientific Officer of KalVista Pharmaceuticals Inc (NASDAQ:KALV), executed a sale of 17,321 shares in the company on January 9, 2024, according to a recent SEC Filing.

Kalvista pharmaceuticals incPharmaceutical companyKalvista pharmaceuticals incEdward feenerChief scientific officerFec filing

KalVista Pharmaceuticals (KALV) Presents Promising Preclinical Data for Oral Factor XIIa Inhibitor Program

KalVista Pharmaceuticals (KALV) Presents Promising Preclinical Data for Oral Factor XIIa Inhibitor Program
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Edward feenerXiia fxiiaAndrew crockettKalvista pharmaceuticals incWall streetVista pharmaceuticalsChief executive officerKallikrein kinin systemKinin systemChief scientific

KalVista Pharmaceuticals, Inc : KalVista Pharmaceuticals Presents Promising Preclinical Data for Oral Factor XIIa Inhibitor Program

First preclinical data presented for structurally diverse oral Factor XIIa inhibitors - Additional Sebetralstat data also presented - KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage

Xiia fxiiaEdward feenerJarrod aldomSally hamptonAndrew crockettExchange commissionDevelopment officerKalvista pharmaceuticals incVp researchCorporate communicationsVista pharmaceuticalsChief executive officerKallikrein kinin systemKinin systemChief scientific officerOral inhibitors